查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1935606

全球幹細胞庫市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Stem Cell Banking Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 143 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計幹細胞庫市場規模將從 2025 年的 115.9 億美元成長到 2034 年的 248.3 億美元，2026 年至 2034 年的複合年成長率為 8.84%。

由於人們對幹細胞治療潛力的認知不斷提高，以及再生醫學需求的日益成長，幹細胞庫市場預計將迎來顯著成長。隨著研究不斷揭示幹細胞在治療包括癌症、神經系統疾病和心血管疾病在內的多種疾病的潛力，對可靠的幹細胞保存方案的需求也隨之飆升。幹細胞庫為幹細胞的採集、處理和儲存提供安全的環境，確保其在未來治療應用中的活性。冷凍保存和生物銀行技術的創新正在提高幹細胞保存的效率和安全性，使這些服務對醫療機構和患者更具吸引力。

此外，個人化醫療的日益普及也對幹細胞庫市場產生了影響。隨著醫療服務提供者越來越認知到根據患者個別需求量身定做治療方案的重要性，自體幹細胞庫的需求也日益成長，患者可以自行儲存幹細胞以備將來使用。這一趨勢在再生醫學領域尤其重要，因為使用患者自身的細胞可以降低排斥反應的風險並改善治療效果。此外，公共幹細胞庫的興起（這些幹細胞庫廣泛提供捐贈幹細胞的儲存服務）正在擴大市場，並促進幹細胞在研究和臨床應用中的使用。

此外，幹細胞治療領域研發投入的不斷增加，正推動幹細胞庫市場的創新。學術機構、研究組織和生物製藥公司之間的合作，促進了幹細胞技術的進步，確保新的採集和保存方法能夠滿足市場不斷變化的需求。消費者對幹細胞庫益處的認知不斷提高，也促進了市場成長，越來越多的人希望透過幹細胞保存來保障自身健康。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球幹細胞庫市場（依來源分類）

  • 市場分析、洞察與預測
  • 胎盤幹細胞（PSCS）
  • 脂肪組織來源幹細胞（ADSCS）
  • 骨髓幹細胞（BMSCs）
  • 人類胚胎幹細胞（HESCs）
  • 牙髓幹細胞（DPSCS）
  • 其他

5. 全球幹細胞庫市場按服務類型分類

  • 市場分析、洞察與預測
  • 樣品保存儲存
  • 樣品分析
  • 樣品處理
  • 檢體採集與運輸

6. 全球幹細胞庫市場（依應用分類）

  • 市場分析、洞察與預測
  • 個性化銀行應用程式
  • 研究用途
  • 臨床應用

7. 全球幹細胞庫市場（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Cord Blood Registry（CBR）Systems
    • Cordlife Group Limited
    • Cryo-Cell International
    • ViaCord
    • Cryo-Save AG
    • LifeCell International
    • StemCyte
    • Global Cord Blood Corporation
    • Smart Cells International
    • Vita34 AG
    • CryoHoldco
簡介目錄
Product Code: VMR11211839

The Stem Cell Banking Market size is expected to reach USD 24.83 Billion in 2034 from USD 11.59 Billion (2025) growing at a CAGR of 8.84% during 2026-2034.

The stem cell banking market is poised for significant growth, driven by the increasing awareness of the therapeutic potential of stem cells and the rising demand for regenerative medicine. As research continues to unveil the capabilities of stem cells in treating various diseases, including cancer, neurological disorders, and cardiovascular diseases, the need for reliable stem cell storage solutions is surging. Stem cell banks provide a secure environment for the collection, processing, and storage of stem cells, ensuring their viability for future therapeutic applications. Innovations in cryopreservation techniques and biobanking technologies are enhancing the efficiency and safety of stem cell storage, making these services more appealing to both healthcare providers and patients.

Moreover, the growing emphasis on personalized medicine is influencing the stem cell banking market. As healthcare providers increasingly recognize the importance of tailoring treatments to individual patient needs, the demand for autologous stem cell banking-where patients store their own stem cells for future use-is rising. This trend is particularly relevant in the context of regenerative therapies, where the use of a patient's own cells can reduce the risk of rejection and improve treatment outcomes. Additionally, the rise of public stem cell banks, which offer accessible storage options for donated stem cells, is expanding the market and promoting the use of stem cells in research and clinical applications.

Furthermore, the increasing focus on research and development in the field of stem cell therapy is fostering innovation in the stem cell banking market. Collaborations between academic institutions, research organizations, and biopharmaceutical companies are driving advancements in stem cell technologies, ensuring that new methods for collection and storage meet the evolving needs of the market. The growing awareness of the benefits of stem cell banking among consumers is also contributing to market growth, as more individuals seek to secure their health and wellness through stem cell preservation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Source

  • Placental Stem Cells (PSCS)
  • Adipose Tissue-Derived Stem Cells (ADSCS)
  • Bone Marrow-Derived Stem Cells (BMSCS)
  • Human Embryo-Derived Stem Cells (HESCS)
  • Dental Pulp-Derived Stem Cells (DPSCS)
  • Others

By Service Type

  • Sample Preservation and Storage
  • Sample Analysis
  • Sample Processing
  • Sample Collection and Transportation

By Application

  • Personalized Banking Applications
  • Research Applications
  • Clinical Application

COMPANIES PROFILED

  • Cord Blood Registry CBR Systems, Cordlife Group Limited, CryoCell International, ViaCord, CryoSave AG, LifeCell International, StemCyte, Global Cord Blood Corporation, Smart Cells International, Vita34 AG, CryoHoldco

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL STEM CELL BANKING MARKET: BY SOURCE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Source
  • 4.2. Placental Stem Cells (PSCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Adipose Tissue-Derived Stem Cells (ADSCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Bone Marrow-Derived Stem Cells (BMSCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Human Embryo-Derived Stem Cells (HESCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Dental Pulp-Derived Stem Cells (DPSCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL STEM CELL BANKING MARKET: BY SERVICE TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Service Type
  • 5.2. Sample Preservation and Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Sample Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Sample Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Sample Collection and Transportation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL STEM CELL BANKING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Personalized Banking Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Research Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Clinical Application Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL STEM CELL BANKING MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Source
    • 7.2.2 By Service Type
    • 7.2.3 By Application
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Source
    • 7.3.2 By Service Type
    • 7.3.3 By Application
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Source
    • 7.4.2 By Service Type
    • 7.4.3 By Application
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Source
    • 7.5.2 By Service Type
    • 7.5.3 By Application
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Source
    • 7.6.2 By Service Type
    • 7.6.3 By Application
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL STEM CELL BANKING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Cord Blood Registry (CBR) Systems
    • 9.2.2 Cordlife Group Limited
    • 9.2.3 Cryo-Cell International
    • 9.2.4 ViaCord
    • 9.2.5 Cryo-Save AG
    • 9.2.6 LifeCell International
    • 9.2.7 StemCyte
    • 9.2.8 Global Cord Blood Corporation
    • 9.2.9 Smart Cells International
    • 9.2.10 Vita34 AG
    • 9.2.11 CryoHoldco